Hacker News Reader

I doubt the US will see much of this, but this is now one of at least 4 high quality vaccines with great, public data banned from use in the US:

Astrazeneca, J&J, Novavax, and Sputnik V.

View on HN

J&J only announced phase 3 results a few days ago and will be up for approval shortly. the Astrazenaca vaccine's results were a mess of p-hacking and mixing methods (they reported a result on a half-size first dose which occurred by accident and in a non-representative population because it looked good).

Personally it makes me more confident in the FDA that they have yet to approve that vaccine.

The AZ vaccine has had data issues in its trial and the FDA is waiting on the US trial arm to finish (likely a month from now) before making a decision. The J&J vaccine has just released data and will likely be authorized in a couple weeks, but manufacturing issues mean that we won’t see tens of millions of doses until April. Novavax is in a similar boat, they won’t have much manufacturing available until late spring and their US trial only started in December so it will run until April.

Reply on news.ycombinator.com